NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.105681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Xiao Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis …. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Sirolimus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Outstanding Youth Science Fund Project of National Natural Science Foundation of China, National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
The mechanistic target of rapamycin (mTOR) forms two distinct complexes: rapamycin-sensitive mTOR complex 1 (mTORC1) and rapamycin-insensitive mTORC2. mTORC2 primarily regulates cell survival by phosphorylating Akt, though the upstream regulation of mTORC2 remains less well-defined than that of mTORC1. In this study, we show that NOP14, a 40S ribosome biogenesis factor and a target of the mTORC1-S6K axis, plays an essential role in mTORC2 signaling. Knockdown of NOP14 led to mTORC2 inactivation and Akt destabilization. Conversely, overexpression of NOP14 stimulated mTORC2-Akt activation and enhanced cell proliferation. Fractionation and coimmunoprecipitation assays demonstrated that the mTORC2 complex was recruited to the rough endoplasmic reticulum through association with endoplasmic reticulum-bound ribosomes. In vivo, high levels of NOP14 correlated with poor prognosis in multiple cancer types. Notably, cancer cells with NOP14 high expression exhibit increased sensitivity to mTOR inhibitors, because the feedback activation of the PI3K-PDK1-Akt axis by mTORC1 inhibition was compensated by mTORC2 inhibition partly through NOP14 downregulation. In conclusion, our findings reveal a spatial regulation of mTORC2-Akt signaling and identify ribosome biogenesis as a potential biomarker for assessing rapalog response in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer,…
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; Z…
- School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China. Electronic address: xiexd8@mail.sysu.edu.cn.
Förderung
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Yan, X., Kuang, B. H., Ma, S., Wang, R., Lin, J., Zeng, Y. X., Xie, X., & Feng, L. (2024). NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.105681
Vancouver
Yan X, Kuang BH, Ma S, Wang R, Lin J, Zeng YX, et al. NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.105681
BibTeX
@article{Yan2024,
author = {Yan, Xiao and Kuang, Bo-Hua and Ma, Shengsuo and Wang, Ruihua and Lin, Jinzhong and Zeng, Yi-Xin and Xie, Xiaoduo and Feng, Lin},
title = {NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.105681}
}
EUVIMED